|
Market Closed -
Nasdaq
16:00:00 2026-08-12 EDT
|
5-day change | 1st Jan Change | ||
| 49.50 USD | -0.80% |
|
-0.76% | +66.05% |
| 08-03 | TG Therapeutics, Inc. Raises Earnings Guidance for the Full Year 2026 | CI |
| 08-03 | TG Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| TG THERAPEUTICS, INC. | Other Pharmaceuticals | -0.80% | -0.76% | +66.05% | +82.52% | +120.29% | 7.08B |  |  | |
- Stock Market
- Stocks
- TGTX Stock
- Charts TG Therapeutics, Inc.
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
